| Literature DB >> 14564000 |
S Hacein-Bey-Abina1, C Von Kalle, M Schmidt, M P McCormack, N Wulffraat, P Leboulch, A Lim, C S Osborne, R Pawliuk, E Morillon, R Sorensen, A Forster, P Fraser, J I Cohen, G de Saint Basile, I Alexander, U Wintergerst, T Frebourg, A Aurias, D Stoppa-Lyonnet, S Romana, I Radford-Weiss, F Gross, F Valensi, E Delabesse, E Macintyre, F Sigaux, J Soulier, L E Leiva, M Wissler, C Prinz, T H Rabbitts, F Le Deist, A Fischer, M Cavazzana-Calvo.
Abstract
We have previously shown correction of X-linked severe combined immunodeficiency [SCID-X1, also known as gamma chain (gamma(c)) deficiency] in 9 out of 10 patients by retrovirus-mediated gamma(c) gene transfer into autologous CD34 bone marrow cells. However, almost 3 years after gene therapy, uncontrolled exponential clonal proliferation of mature T cells (with gammadelta+ or alphabeta+ T cell receptors) has occurred in the two youngest patients. Both patients' clones showed retrovirus vector integration in proximity to the LMO2 proto-oncogene promoter, leading to aberrant transcription and expression of LMO2. Thus, retrovirus vector insertion can trigger deregulated premalignant cell proliferation with unexpected frequency, most likely driven by retrovirus enhancer activity on the LMO2 gene promoter.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14564000 DOI： 10.1126/science.1088547
Source DB: PubMed Journal: Science ISSN： 0036-8075 Impact factor: 47.728